[
    "Production and distribution: Producing and distributing a new vaccine can be a logistical challenge. The manufacturing process can be complex and time-consuming, and there may be limited supply initially, which could lead to unequal distribution and access to the vaccine.",
    "Cost: Developing a new vaccine can be expensive, and the cost of production and distribution may be prohibitive for some countries or populations. This could lead to unequal access to the vaccine and exacerbate health disparities.",
    "Resistance to vaccination: Some people may be hesitant to get vaccinated due to misinformation or fear. This could lead to a decrease in the effectiveness of the vaccine and a prolonged outbreak of the disease.",
    "Vaccine efficacy: The efficacy of a new vaccine may be unknown until it is tested on a large population. If the vaccine is not effective, it may be a waste of resources and could potentially cause harm.",
    "Legal and regulatory issues: Developing a new vaccine may require regulatory approval and compliance with strict guidelines. This can be a lengthy and complex process, and there may be legal and regulatory issues that arise during the development and distribution of the vaccine."
]